ORIENTBIO Inc. (002630) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.026x

Based on the latest financial reports, ORIENTBIO Inc. (002630) has a cash flow conversion efficiency ratio of 0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.77 Billion ≈ $1.20 Million USD) by net assets (₩67.73 Billion ≈ $45.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of ORIENTBIO Inc. to measure how many days the company can operate on defensive assets alone.

ORIENTBIO Inc. - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how ORIENTBIO Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

ORIENTBIO Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ORIENTBIO Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Evermore Chemical Industry Co Ltd TW:1735	0.061x
Suprema HQ Inc KQ:094840	0.015x
Dominari Holdings Inc. NASDAQ:DOMH	-0.917x
Eureka Acquisition Corp Unit NASDAQ:EURKU	-0.006x
E & M Computing Ltd TA:EMCO	0.118x
Menderes Tekstil Sanayi ve Ticaret AS IS:MNDRS	0.046x
Metrofile JSE:MFL	0.237x
Company K Partners Limited KQ:307930	0.108x

Annual Cash Flow Conversion Efficiency for ORIENTBIO Inc. (2007–2025)

The table below shows the annual cash flow conversion efficiency of ORIENTBIO Inc. from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 002630 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	₩71.85 Billion ≈ $48.69 Million	₩752.29 Million ≈ $509.82K	0.010x	-76.28%
2024-03-31	₩85.10 Billion ≈ $57.67 Million	₩3.76 Billion ≈ $2.55 Million	0.044x	+171.70%
2023-03-31	₩71.39 Billion ≈ $48.38 Million	₩1.16 Billion ≈ $786.07K	0.016x	-42.52%
2022-03-31	₩83.19 Billion ≈ $56.38 Million	₩2.35 Billion ≈ $1.59 Million	0.028x	-84.30%
2021-03-31	₩48.55 Billion ≈ $32.90 Million	₩8.74 Billion ≈ $5.92 Million	0.180x	+339.61%
2020-03-31	₩51.96 Billion ≈ $35.21 Million	₩-3.90 Billion ≈ $-2.65 Million	-0.075x	+59.21%
2019-03-31	₩62.65 Billion ≈ $42.45 Million	₩-11.54 Billion ≈ $-7.82 Million	-0.184x	-648.68%
2018-03-31	₩79.92 Billion ≈ $54.16 Million	₩-1.97 Billion ≈ $-1.33 Million	-0.025x	+52.82%
2017-03-31	₩97.94 Billion ≈ $66.38 Million	₩-5.11 Billion ≈ $-3.46 Million	-0.052x	-621.81%
2016-03-31	₩91.29 Billion ≈ $61.87 Million	₩912.43 Million ≈ $618.34K	0.010x	-58.01%
2015-03-31	₩67.35 Billion ≈ $45.64 Million	₩1.60 Billion ≈ $1.09 Million	0.024x	-32.14%
2014-03-31	₩61.85 Billion ≈ $41.91 Million	₩2.17 Billion ≈ $1.47 Million	0.035x	-57.12%
2013-03-31	₩62.29 Billion ≈ $42.21 Million	₩5.09 Billion ≈ $3.45 Million	0.082x	+71.95%
2011-03-31	₩65.49 Billion ≈ $44.38 Million	₩3.11 Billion ≈ $2.11 Million	0.048x	-68.59%
2010-03-31	₩61.77 Billion ≈ $41.86 Million	₩9.35 Billion ≈ $6.34 Million	0.151x	+347.50%
2007-03-31	₩44.86 Billion ≈ $30.40 Million	₩1.52 Billion ≈ $1.03 Million	0.034x	--

About ORIENTBIO Inc.

KO:002630 Korea Biotechnology

Market Cap

$72.49 Million

₩106.96 Billion KRW

Market Cap Rank

#20554 Global

#1124 in Korea

Share Price

₩902.00

Change (1 day)

-4.04%

52-Week Range

₩467.00 - ₩996.00

All Time High

₩6770.89